Intracellular delivery of doxorubicin encapsulated in novel pH-responsive chitosan/heparin nanocapsules

被引:36
作者
Thomas, Midhun B. [1 ]
Radhakrishnan, Krishna [1 ]
Gnanadhas, Divya P. [2 ]
Chakravortty, Dipshikha [2 ]
Raichur, Ashok M. [1 ,3 ]
机构
[1] Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India
[2] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India
[3] Univ Johannesburg, Dept Appl Chem, Doornfontein, South Africa
关键词
drug delivery; layer-by-layer; electrostatic interaction; biocompatible; MOLECULAR-WEIGHT; GROWTH-FACTOR; RELEASE; POLYMERIZATION; SCAFFOLDS; HEPARIN;
D O I
10.2147/IJN.S37737
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
A novel polyelectrolyte nanocapsule system composed of biopolymers, chitosan and heparin has been fabricated by the layer-by-layer technique on silica nanoparticles followed by dissolution of the silica core. The nanocapsules were of the size range 200 +/- 20 nm and loaded with the positively charged anticancer drug doxorubicin with an efficiency of 89%. The loading of the drug into the capsule happens by virtue of the pH-responsive property of the capsule wall, which is determined by the pKa of the polyelectrolytes. As the pH is varied, about 64% of the drug is released in acidic pH while 77% is released in neutral pH. The biocompatibility, efficiency of drug loading, and enhanced bioavailability of the capsule system was confirmed by MTT assay and in vivo biodistribution studies.
引用
收藏
页码:267 / 273
页数:7
相关论文
共 27 条
[1]   PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect [J].
Acharya, Sarbari ;
Sahoo, Sanjeeb K. .
ADVANCED DRUG DELIVERY REVIEWS, 2011, 63 (03) :170-183
[2]   MOLECULAR-WEIGHT DEPENDENCY OF THE HEPARIN POTENTIATED INHIBITION OF THROMBIN AND ACTIVATED FACTOR-X - EFFECT OF HEPARIN NEUTRALIZATION IN PLASMA [J].
ANDERSSON, LO ;
BARROWCLIFFE, TW ;
HOLMER, E ;
JOHNSON, EA ;
SODERSTROM, G .
THROMBOSIS RESEARCH, 1979, 15 (3-4) :531-541
[3]   Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications [J].
Berger, J ;
Reist, M ;
Mayer, JM ;
Felt, O ;
Gurny, R .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 57 (01) :35-52
[4]   Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy [J].
Bisht, Savita ;
Maitra, Amarnath .
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2009, 1 (04) :415-425
[5]   Nanoengineering of inorganic and hybrid hollow spheres by colloidal templating [J].
Caruso, F ;
Caruso, RA ;
Möhwald, H .
SCIENCE, 1998, 282 (5391) :1111-1114
[6]   Fuzzy nanoassemblies: Toward layered polymeric multicomposites [J].
Decher, G .
SCIENCE, 1997, 277 (5330) :1232-1237
[7]  
Donath E, 1998, ANGEW CHEM INT EDIT, V37, P2202, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2201::AID-ANIE2201>3.0.CO
[8]  
2-E
[9]  
FORNARI FA, 1994, MOL PHARMACOL, V45, P649
[10]   Enzyme-responsive release of encapsulated proteins from biodegradable hollow capsules [J].
Itoh, Yuki ;
Matsusaki, Michiya ;
Kida, Toshiyuki ;
Akashi, Mitsuru .
BIOMACROMOLECULES, 2006, 7 (10) :2715-2718